U.S. Markets closed

Intel Could Win All of Apple's Modem Orders This Year

Ashraf Eassa, The Motley Fool

Chip giant Intel (NASDAQ: INTC) entered the cellular modem business in 2011 with the acquisition of Infineon's wireless division. Since then, Intel has poured a lot of resources into that business with the aim of transforming it from a technology laggard into a leader.

This business scored its first big win under Intel's wing in the second half of 2016, when Apple (NASDAQ: AAPL) chose to use Intel's XMM 7360 LTE modem to provide the cellular capabilities for a portion of its iPhone 7-series devices. Intel, yet again, won a portion of the modem orders for the current iPhone 8-series and iPhone X device with its XMM 7480. 

Intel's XMM 7560 LTE modem next to a pencil eraser and penny.

Image source: Intel.

Now, the XMM 7360 and XMM 7480 were missing a critical feature -- support for a wireless standard known as CDMA. This meant that iPhones based on Intel's modems wouldn't work on several major networks that used the standard, capping the share that Intel could gain in the iPhone.

However, Intel's latest XMM 7560 modem supports CDMA, which could allow the chip giant to, theoretically, win the entirety of Apple's modem orders for the coming iPhone product cycle. And, according to one analyst, that's exactly what's set to happen.

High yields, potential for 100% share

A previous report from Fast Company stated that "Apple is expecting Intel to supply 70% of the modem chips inside the new iPhone models," with Intel potentially getting all of the orders for the 2019 iPhones "if all goes well."

At the time of that report, Fast Company said that Intel was struggling with the yield rates -- that is, the percentage of the modems produced that ultimately turned out to be salable -- of the XMM 7560 chips.

"Only just more than half of the chips being produced are keepers," Fast Company said.

It seems that Intel worked through those yield issues after all. Analysts with Baird (via StreetInsider) claim that their "checks" revealed that yield rates on the XMM 7560 were "high" and that Intel could, in fact, win all of Apple's modem orders for the new iPhones in the second half of 2018. 

Although the Fast Company report said that Intel was expecting to get 70% of the modem orders for the new iPhones this year, it did say that "there's also a chance that if Intel can produce enough chips on time and on budget it could get more of the planned 70% [iPhone modem share]"

Perhaps this upside scenario is set to play out?

Business impact

Apple currently offers the following iPhone product lines:

  • iPhone SE
  • iPhone 6s/6s Plus
  • iPhone 7/7 Plus
  • iPhone 8/8 Plus
  • iPhone X

The iPhone SE and iPhone 6s-series devices don't use Intel modems at all, and I'd be surprised if Intel even had half of the modem orders for the iPhone 7-series, iPhone 8-series, and iPhone X devices.

As the iPhone 6s/6s Plus roll off and new models are introduced, Intel's share of Apple's cellular modem business is set to rise. Not only should Intel have a greater percentage of the modem shipments in Apple's latest (and best-selling) models, but its average cellular modem content in the legacy models should go up, too.

Moreover, if Intel is successful in capturing all of Apple's modem business in either this year's models or the following years' models, then the company could be on track to eventually be the sole cellular modem supplier for Apple's iPhones.

A while back, I estimated Intel's modem business from the iPhone at "over $1 billion per year in revenue." If Intel is successful in capturing all of Apple's cellular modem business, then the company could be set to rake in more than $2 billion per year in revenue.

That's not a game-changer for Intel, which is on track to generate more than $68 billion in revenue this year, but it'd certainly be a nice chunk of change.

More From The Motley Fool

Ashraf Eassa has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Apple. The Motley Fool has the following options: long January 2020 $150 calls on Apple and short January 2020 $155 calls on Apple. The Motley Fool has a disclosure policy.

  • Mega Millions $1.6 Billion Jackpot Also Comes With a Mega Millions Tax Bill
    Finance
    Fortune

    Mega Millions $1.6 Billion Jackpot Also Comes With a Mega Millions Tax Bill

    With a jackpot of $1.6 billion, tonight’s Mega Millions lottery drawing is the biggest in history. The Mega Millions drawing will be held Tuesday night at 11 p.m. ET—and the odds are categorically against you. The Mega Millions tax bite, though, is pretty solid.

  • Business
    Benzinga

    Q3 Earnings Preview For Capital One Financial

    On Tuesday, Capital One Financial (NYSE: COF) will report its last quarter's earnings. Here is Benzinga's take on the company's release. Earnings and Revenue Based on Capital One Financial management projections, analysts predict EPS of $2.87 on revenue

  • 2 More Marijuana Stocks Are Moving to the NYSE
    Business
    Motley Fool

    2 More Marijuana Stocks Are Moving to the NYSE

    This year, we've witnessed GW Pharmaceuticals gain approval in the U.S. for the first cannabis-derived drug, and we watched as Vermont legalized recreational marijuana use entirely through the legislative process. This began with Cronos Group at the end of February, when it chose to list its shares on the Nasdaq. It was followed just a few months later by Canopy Growth Corp., which became the first marijuana stock to list on the NYSE.

  • Companies Say They're Ready to Move Supply Chains From China
    News
    Bloomberg

    Companies Say They're Ready to Move Supply Chains From China

    U.S. President Donald Trump imposed a 10 percent tariff on $200 billion of Chinese imports in September -- following an earlier round of tariffs on $50 billion of goods -- and promised to raise the duty to 25 percent in January. "We’re pro-actively taking action," Todd Bluedorn, chief executive officer of the Texas-based HVAC company, told analysts during an Oct. 22 earnings call.

  • Why Investors Are Paying a Premium for These 3 Biotech Stocks
    Business
    Motley Fool

    Why Investors Are Paying a Premium for These 3 Biotech Stocks

    Amarin stock exploded in September because it looks like Vascepa will become the next go-to drug for this enormous population. During the 8,179-patient Reduce-It trial, patients given Vascepa in addition to their normal statin treatments were 25% less likely to suffer a major cardiovascular event such as a heart attack. Over the past year, Amarin Corporation actually lost $92 million because sales of Vascepa just haven't kept pace with operating expenses.

  • 5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade
    Business
    Motley Fool

    5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade

    October has been a wake-up call for investors that the stock market won't go up in a straight line, even if we'd like it to. Sure, Bank of America (NYSE: BAC) has seen its stock catapult higher from its Great Recession lows, but its forward P/E of 9.8 would represent a more-than-decade low for the stock.

  • Suze Orman missed the point of retirement, and that’s why she went back to work
    News
    MarketWatch

    Suze Orman missed the point of retirement, and that’s why she went back to work

    Suze Orman did a smackdown of the FIRE (Financial Independence/Retire Early) movement on Paula Pant’s podcast. Coach Carson posted a balanced, informative response, appreciating Suze’s admonition to be sure you have enough for a risk-free retirement. Suze enumerated a string “what can go wrong” scenarios as evidence that early retirement (on less than $10 million) leaves you vulnerable when life hands you lemons — a whole tree of lemons.

  • MARKETS: Here's why stocks are selling off right now and what a bottom would look like
    Business
    Yahoo Finance Video

    MARKETS: Here's why stocks are selling off right now and what a bottom would look like

    Live from the floor of the New York Stock Exchange, Yahoo Finance's Jared Blikre joins Seana Smith to discuss the latest market moves.

  • The stock market's 'dead cat bounce' is over and the rolling bear market is making a comeback, Morgan Stanley says
    Business
    Business Insider

    The stock market's 'dead cat bounce' is over and the rolling bear market is making a comeback, Morgan Stanley says

    The stock market may have bounced back from its sharp sell-off at the beginning of October, but Morgan Stanley says the selling will pick back up soon. The firm expects the S&P 500 to slide back below the 200-day moving average, a key technical level. Tread carefully in tech and consumer discretionary, Morgan Stanley warns.

  • Tesla Skeptic Andrew Left Is Now Long on ‘Proven Hit’ Model 3
    Business
    Bloomberg

    Tesla Skeptic Andrew Left Is Now Long on ‘Proven Hit’ Model 3

    Citron Research’s Andrew Left, a vocal and long-term Tesla short, said in a report Tuesday that the electric-car maker is snatching customers from BMW, Mercedes, Toyota and Honda. In a Bloomberg Television interview, he said Chief Executive Officer Elon Musk has distracted investors from a company that’s turning a corner. “Elon Musk has made such a sideshow of himself that people started to forget about -- including myself -- the underlying business,” Left said on Bloomberg TV.

  • How Energy Transfer’s Returns Stack Up with Peers
    Finance
    Market Realist

    How Energy Transfer’s Returns Stack Up with Peers

    How Energy Transfer Stock Has Fared (Continued from Prior Part) Total returns Energy Transfer (ET) stock has returned (including dividends) only 0.5% so far this year. In comparison, the Alerian MLP ETF (AMLP) returned approximately 3%, and broader markets

  • These stocks may be sacrificed in a cold war with China
    COL
    CNBC Videos

    These stocks may be sacrificed in a cold war with China

    Jim Cramer says the escalation in the United States' trade war with China could end in an outright cold war that debilitates parts of the stock market.

  • Business
    Reuters

    Caterpillar tries to allay earnings concerns after shares tank

    Caterpillar Inc (CAT.N) tried on Tuesday to ease mounting concerns about China and global demand after it affirmed its 2018 profit estimate, a move that investors feared signalled a cap in earnings growth and sparked a sell-off in its shares. The Deerfield, Illinois-based company has boosted the full-year profit outlook twice in the first two quarters of this year. The move came days after China reported the weakest economic growth since the global financial crisis, and the International Monetary Fund cut the global growth outlook for 2018 and 2019.

  • Investors are ‘riding the cannabis bronco’ as pot stocks ebb and flow
    Finance
    Yahoo Finance Canada

    Investors are ‘riding the cannabis bronco’ as pot stocks ebb and flow

    Craig Wiggins is a member of the increasingly popular trio of independent marijuana analysts known as “TheCannalysts.” He said the volatility speaks to the number of rookie retail investors that piled into pot stocks ahead of recreational legalization in Canada. You got to get used to being thrown every once in a while,” Wiggins said.

  • A huge Amazon warehouse Prime Day outage may have been caused by moving off Oracle's databases
    Business
    Business Insider

    A huge Amazon warehouse Prime Day outage may have been caused by moving off Oracle's databases

    On Prime Day, Amazon's website crashed, while one of its biggest warehouses also experienced a technical outage that delayed thousands of package deliveries. According to documents obtained by CNBC, the outage was caused by Amazon moving its database for an Ohio warehouse off of Oracle's to its own. Amazon is planning to move completely off Oracle's database by 2020, but Oracle thinks it's a long shot.

  • Why These 3 Top Marijuana Stocks Slumped Today
    Business
    Motley Fool

    Why These 3 Top Marijuana Stocks Slumped Today

    With earnings season hitting a crescendo this week, investors are looking closely at the specific prospects for certain corners of the market, and that's contributing to disparities among the various major benchmarks followed most often by investors. Amid the crosscurrents, marijuana stocks took particularly hard hits, and New Age Beverages (NASDAQ: NBEV), Tilray (NASDAQ: TLRY), and Canopy Growth (NYSE: CGC) were among the worst performers on the day. All three of these stocks have given back some of their gains following the long-awaited legalization of recreational cannabis in the Canadian market last week. In the month leading up to the Oct. 17 start date for legal cannabis sales, New Age Beverages tripled in value, while Tilray had more than doubled since the end of August, and Canopy Growth had seen more modest gains of between 10% and 20%.

  • News
    CNBC

    Here's how much money you should have saved by 50

    Fidelity, the nation's largest retirement-plan provider, recommends having the equivalent of six times your annual salary saved. To get to that number, Fidelity recommends saving 15 percent of your annual income. Make sure to invest these funds instead of leaving them in a traditional low-interest savings account.

  • Why Nektar Therapeutics Crashed 17.2% Today
    Business
    Motley Fool

    Why Nektar Therapeutics Crashed 17.2% Today

    After delivering a disappointing update on NKTR-214 in cancer patients this summer, Nektar Therapeutics' (NASDAQ: NKTR) shares have been struggling. The company didn't report any news today, so a negative report issued by Plainview LLC this month may be to blamed for its 17.2% tumble today. In February, Bristol-Myers Squibb (NYSE: BMY) inked a blockbuster deal to license rights to NKTR-214 following positive data last year for NKTR-214's use alongside Bristol-Myers' Opdivo.

  • Trump’s Tax Push to Help Middle Class Could Help Top Earners Too
    Politics
    Bloomberg

    Trump’s Tax Push to Help Middle Class Could Help Top Earners Too

    It’s still unclear how Trump will propose to reduce the tax burden on middle-class Americans, but one of the most straightforward ways would be to lower rates by 10 percent for single filers making up to $82,500. U.S. income tax rates are graduated and income dollars get taxed in chunks as they move up through the brackets -- which means wealthy Americans would also get to apply the reduced rate on their first dollars of income. “A millionaire gets the same size tax cut,” said Kyle Pomerleau, an economist at the conservative Tax Foundation.

  • 3 Dividend Stocks to Fund Your Retirement Nest Egg
    Business
    Motley Fool

    3 Dividend Stocks to Fund Your Retirement Nest Egg

    Dividend stocks play a key role in a good retirement portfolio, but investing indiscriminately in companies just because they offer a big yield or have a recent history of payout growth will likely cause your portfolio's performance to fall short of its

  • Petrobras Stock Upgraded: What You Need to Know
    Business
    Motley Fool

    Petrobras Stock Upgraded: What You Need to Know

    Does Brazilian oil major Petroleo Brasileiro (NYSE: PBR) (NYSE: PBR-A) make for a good investment? There are a lot of reasons to answer, "No." From 2014 to 2017, Petrobras stock lost money for its shareholders. Unusual for an oil major, Petrobras doesn't even pay much of a dividend to its shareholders -- a mere 0.8%, or less than half the average dividend yield on the S&P 500.

  • S&P 500 closes down for fifth day as stocks retreat in wake of China selloff
    News
    MarketWatch

    S&P 500 closes down for fifth day as stocks retreat in wake of China selloff

    U.S. stocks bounced off intraday lows and major indexes trimmed early losses Tuesday, but the S&P 500 still finished lower for a fifth session as a big drop in the Chinese market revived fresh questions about the global economy. The Dow Jones Industrial Average (DJIA) fell 125.98, or 0.5%, to 25,191.43 after being down more than 500 points earlier. (DJIA)On Monday, Dow industrials and the S&P 500 closed lower while the Nasdaq bucked the trend to edge higher.

  • What to Expect from Bristol-Myers Squibb’s Q3 Earnings
    Finance
    Market Realist

    What to Expect from Bristol-Myers Squibb’s Q3 Earnings

    Bristol-Myers Squibb (BMY) is expected to report its third-quarter earnings on October 25. Analysts expect Bristol-Myers Squibb’s revenues to increase 8.87% from $5.25 billion in the third quarter of 2017 to $5.72 billion in the third quarte of 2018. In the last four quarters, Bristol-Myers Squibb’s revenue growth has been 3.93%–10.89%.

  • 4 Things Aurora Cannabis Did Right Before Its NYSE Debut
    Business
    Motley Fool

    4 Things Aurora Cannabis Did Right Before Its NYSE Debut

    Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) has sought to make it even easier for U.S. investors to buy its shares by arranging to have its shares listed on the New York Stock Exchange. Beginning tomorrow, Oct. 23, Aurora will join the elite group of cannabis companies whose shares trade on major U.S. exchanges. Getting ready for the increased exposure that a NYSE listing brings takes time and effort, and Aurora Cannabis hasn't wasted any time.

  • Caterpillar's Q3 beat expectations, shares tumble
    Finance
    Yahoo Finance

    Caterpillar's Q3 beat expectations, shares tumble

    A Caterpillar Inc. equipment is on display for sale at a retail site in San Diego, California, U.S., March 3, 2017. Global construction equipment giant Caterpillar (CAT) announced quarterly results that were a bit better than expected. Caterpillar’s construction industries business segment sales grew 16% to $5.7 billion.